摘要:
The present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema containing a mixed extract of Hedera helix leaves and Coptis chinensis as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema further containing an extract of Rheum palmatum , Puerariae radix, Ginkgo leaves, Cassiae semen , blueberry, bilberry, raspberry, or grape seeds as an active ingredient, in addition to the mixed extract of Hedera helix leaves and Coptis chinensis.
摘要:
Methods for treating an individual to improve cognitive function are provided. In the subject methods, an effective amount of a noncompetitive GABA A ionophore blocker (e.g. pentylenetetrazole, picrotoxin or bilobalide ) is administered to the individual, resulting in an improvement in cognitive function of the host. The subject methods find use in a variety of different applications, like Down Syndrome, Phenylketonuria, Fragile-X-Syndrome, Neurofibromatosis-1, Maple Syrup Urine Disease or Rett Syndrome .
摘要:
The present invention relates to compositions containing plant materials or extracts with inhibitory effect on a 5-HT3a and/or NK-1 receptor for preventing or treating idiopathic vomiting.
摘要:
A composition of a non specific multiple cytokine and cell growth factor inhibitor suitable for use in treating skin diseases involving excessive skin cell growth containing preferably synergistic association of at least two tannins rich plant extracts such as those selected among the plant extracts of Acacia catechu, Salvia officinalis, Vitis vinifera, Vaccinium macrocarpon or Vaccinium myrtillus fruit, Quercus oak bark, Ginko biloba, Salix alba, Mimosa tenuiflora, Echinacea sp, Tenacetum parthenium, Camillia sinensis, or Sambucus nigra.
摘要:
Process for removing pesticides from Ginkgo biloba extracts, which involves submitting an extract obtained by conventional methods to the following steps: a. Liquid-liquid extraction of the extract to obtain a medium polarity fraction containing ginkgo terpenes and pesticides not removable with hexane, and a high polarity fraction containing ginkgo flavone glycosides; b. crystallisation from the medium polarity fraction obtained at step a) to give an intermediate with a ginkgolide content of not less than 50%; c. crystallisation from the residual solution obtained at step b) to give an intermediate with a bilobalide content of not less than 50%; d. mixing of the high polarity fraction obtained at step a) with the ginkgo terpene intermediate and the bilobalide intermediate obtained at steps b) and c).